Product Information Gefitinib Tablets 250 mg are prescription targeted anticancer medicines belonging to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) class. They are prescribed for selected patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). By specifically targeting abnormal EGFR activity, Gefitinib helps reduce cancer cell growth while allowing a more targeted treatment approach. What Special Precautions Should I Follow? Important precautions include: Inform your doctor about any history of lung disease, liver disorders, or eye problems. Routine liver function tests and clinical monitoring may be recommended during treatment. Tell your healthcare provider about all prescription medicines, herbal supplements, and over-the-counter products you are taking, as some medicines may interact with Gefitinib. Women who are pregnant or planning pregnancy should avoid this medicine unless specifically advised by their physician. What Special Dietary Instructions Should I Follow? Maintain good hydration unless otherwise instructed. Follow a balanced, nutritious diet to support overall health during treatment. Discuss any dietary supplements with your healthcare provider before use. Avoid making significant dietary changes without consulting your treating physician. What Other Information Should I Know? Keep out of the reach of children. Do not share prescription medicines with others. Attend all scheduled medical appointments and laboratory monitoring. Dispose of unused or expired medicines according to local pharmaceutical disposal regulations. Always verify batch details and expiry dates before use. Why Choose Gefitinib from India? ✔ GMP compliant manufacturing facilities ✔ Reliable international pharmaceutical exporter ✔ Bulk quantities for commercial procurement ✔ Secure export packaging ✔ Competitive global supply chain Frequently Asked Questions 1. What is Gefitinib Tablets 250 mg used for? Gefitinib is prescribed for selected patients with EGFR mutation-positive non-small cell lung cancer under the supervision of an oncology specialist. 2. Can Gefitinib be purchased in bulk for hospitals? Yes. Licensed hospitals, pharmaceutical distributors, government procurement agencies, and authorized importers may purchase commercial quantities according to local regulations. 3. Is a prescription required? Yes. Gefitinib Tablets are prescription-only medicines and should be used only under medical supervision. 4. What documents are available for export orders? Export orders are supported with essential shipping and quality documents, subject to the destination country's import regulations. 5. Why do global buyers choose Indian pharmaceutical suppliers? Indian pharmaceutical exporters are recognized for international manufacturing standards, competitive pricing, reliable production capacity, and efficient global distribution networks. Gefitinib Tablets 250 mg Supplier from India Buy Gefitinib Tablets Online Gefitinib Exporter India Lung Cancer Medicine Export Oncology Tablet Distributor Bulk Gefitinib Tablets Targeted Cancer Medicine Supplier Gefitinib Wholesale Distributor 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #Gefitinib250mg #GefitinibTablets #TargetedTherapy #LungCancerMedicine #EGFRInhibitor #OncologyMedicine #MedicineSupplierIndia #PharmaceuticalExporter #CancerCare #HospitalProcurement #GlobalHealthcare #BulkPharma #HealthcareDistribution #IndianPharma #OncologyDistributor #MedicalExports #PrecisionMedicine #WorldwidePharma #CancerTreatment #ErnestPharmaceutical

Geftib 250mg (Gefitinib) Tablet Geftib 250mg Tablet contains Gefitinib, a targeted therapy medicine used in the treatment of non-small cell lung cancer (NSCLC). Gefitinib belongs to the class of medicines known as tyrosine kinase inhibitors, which work by blocking signals that stimulate the growth and spread of cancer cells. Gefitinib tablets are commonly prescribed for patients with EGFR mutation-positive lung cancer and should be taken under the supervision of a qualified healthcare professional. Ernest Oncology supplies Geftib 250mg (Gefitinib) Tablets globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Geftib Tablet Generic Name: Gefitinib Strength: 250mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Packaging Type: Tablet Strip / Box Route of Administration: Oral Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Geftib 250mg Tablet Geftib (Gefitinib) Tablet is used in the treatment of: • Non-Small Cell Lung Cancer (NSCLC) • EGFR Mutation Positive Lung Cancer • Advanced or Metastatic Lung Cancer It helps slow the growth of cancer cells and may reduce the spread of tumors. How Geftib Tablet Works Gefitinib works by blocking the epidermal growth factor receptor (EGFR) on cancer cells. By inhibiting this receptor, the medicine prevents signals that promote cancer cell growth and division. Administration Geftib 250mg Tablet should be taken: • As prescribed by a qualified healthcare professional • Usually once daily • Swallowed whole with water • With or without food Dosage and treatment duration depend on the patient’s medical condition and response to therapy. Possible Side Effects Some patients may experience: • Diarrhea • Skin rash • Nausea • Loss of appetite • Fatigue • Dry skin Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from moisture and sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

GEFTINAT 250MG Tablet (Gefitinib) Global Supplier & Oncology Medicine Exporter – Ernest Impex GEFTINAT 250MG Tablet contains Gefitinib, a targeted anti-cancer medication used for the treatment of non-small cell lung cancer (NSCLC), particularly in patients with EGFR mutation-positive tumors. Ernest Impex is a trusted pharmaceutical exporter from India, supplying GEFTINAT 250MG Tablets globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and international healthcare procurement agencies. Pharmaceutical buyers and healthcare providers in Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely on Ernest Impex for bulk supply of Gefitinib tablets with reliable global logistics, competitive export pricing, and high-quality pharmaceutical sourcing. What is GEFTINAT 250MG Tablet? GEFTINAT 250MG Tablet contains Gefitinib, an EGFR (Epidermal Growth Factor Receptor) Tyrosine Kinase Inhibitor, used in targeted cancer therapy. In many lung cancers, EGFR mutations cause cancer cells to grow and divide rapidly. Gefitinib blocks the EGFR signaling pathway responsible for cancer cell proliferation. By blocking these signals, the medicine helps: • Slow tumor growth • Prevent cancer cell multiplication • Reduce cancer spread • Improve treatment outcomes Due to this targeted mechanism, Gefitinib is widely used in modern precision oncology treatment protocols worldwide. Mechanism of Action The active ingredient Gefitinib selectively inhibits the EGFR tyrosine kinase enzyme. Its anti-cancer action includes: • Blocking EGFR receptor signaling • Preventing cancer cell growth and division • Inducing apoptosis (programmed cancer cell death) • Reducing tumor progression This targeted action makes GEFTINAT tablets effective in treating EGFR mutation-positive lung cancer patients. Medical Uses of GEFTINAT 250MG Tablet GEFTINAT tablets are commonly prescribed for: • Non-Small Cell Lung Cancer (NSCLC) • EGFR mutation-positive lung cancer • Advanced or metastatic lung cancer • Targeted therapy in oncology treatment programs Gefitinib is widely used in specialized oncology hospitals and cancer research centers worldwide. Product Information Product Name: GEFTINAT 250MG Tablet Generic Name: Gefitinib Strength: 250 mg Dosage Form: Oral Tablet Therapeutic Category: Anti-Cancer / EGFR Tyrosine Kinase Inhibitor Packaging: Blister pack / Export packaging Shelf Life: 24–36 months Storage: Store below 25°C in a cool and dry place Benefits of GEFTINAT Tablets • Advanced targeted therapy for lung cancer • Effective EGFR inhibitor used in oncology treatment • Helps slow cancer progression • Oral tablet for convenient treatment • Widely used in precision cancer therapy • Trusted targeted lung cancer medication worldwide Why Choose Ernest Impex? Ernest Impex is a leading global pharmaceutical exporter, supplying high-quality medicines to healthcare providers worldwide. Key advantages include: • GMP certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable global pharmaceutical supply chain • OEM / Private Label pharmaceutical supply available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted exporter of oncology medicines and specialty drugs Export Documentation Provided Ernest Impex provides complete export documentation including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth international pharmaceutical import and regulatory compliance. 📞 Contact Ernest Impex – Pharmaceutical Exporter from India 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

About Imatinib Mesylate Tablets Imatinib Mesylate Tablets are prescription oncology medicines belonging to the tyrosine kinase inhibitor (TKI) class. They are widely used in specialized oncology and hematology treatment programs under the supervision of qualified medical professionals. The tablets are manufactured following stringent pharmaceutical quality standards and supplied to regulated healthcare markets through licensed distribution networks. Product Profile Specification: Information Generic Name: Imatinib Mesylate Dosage Form: Oral Tablets Available Strengths: 100 mg & 400 mg Therapeutic Category: Oncology Medicine Drug Class: :Tyrosine Kinase Inhibitor (TKI) Prescription Status: Prescription Only Country of Origin: India Medical Applications: Hematology treatment programs Oncology management protocols Long-term physician-supervised therapy Hospital cancer care services Specialized oncology clinics Clinical treatment pathways Safety & Clinical Guidance: Use the medicine only under medical supervision. Attend scheduled follow-up appointments. Inform healthcare providers about existing medical conditions and concurrent medications. Follow laboratory monitoring recommendations when advised. Report unusual symptoms promptly to the treating physician. Why Choose Our Pharmaceutical Export Services: Consistent international product availability Bulk supply for institutional buyers Experienced pharmaceutical export team Timely worldwide dispatch Complete export documentation support Quality-focused sourcing network Competitive commercial pricing Regulatory & Export Documentation Certificate of Analysis (COA) Certificate of Origin (COO) Commercial Invoice Packing List Batch Certificate Product Specification Sheet Manufacturing Compliance Docum Imatinib Mesylate Tablets 100 mg Imatinib Mesylate Tablets 400 mg Dasatinib Tablets Nilotinib Capsules Bosutinib Tablets Ponatinib Tablets Erlotinib Tablets Gefitinib Tablets Frequently Asked Questions 1. Which strengths of Imatinib Mesylate Tablets are available for export? The commonly supplied strengths are 100 mg and 400 mg, subject to manufacturer availability and destination market requirements. 2. Who can place bulk orders for Imatinib Mesylate Tablets? Licensed pharmaceutical importers, hospitals, oncology distributors, government procurement agencies, and authorized healthcare wholesalers can procure bulk quantities. 3. Are export documents provided with international shipments? Yes. Eligible orders can be accompanied by COA, COO, CPP (where applicable), commercial invoices, packing lists, batch documentation, and other required regulatory documents. 4. Which countries frequently source Imatinib Mesylate Tablets? Demand is strong in the United States (Washington, D.C.), United Kingdom (London), Australia (Canberra), Canada (Ottawa), Singapore, France (Paris), Germany (Berlin), UAE (Abu Dhabi), Saudi Arabia (Riyadh), South Africa (Pretoria), and Nigeria (Abuja). 5. Why do global healthcare buyers choose Indian exporters for Imatinib Mesylate Tablets? Indian pharmaceutical exporters are recognized for supplying quality-assured oncology medicines, dependable bulk availability, competitive commercial pricing, regulatory documentation support, and efficient worldwide distribution tailored to institutional healthcare procurement. #ImatinibMesylate #Imatinib100mg #Imatinib400mg #TyrosineKinaseInhibitor #TargetedTherapy #OncologyMedicine #CancerCare #PharmaceuticalExporter #WholesaleMedicines #HospitalPharmacy #MedicineSupplier #IndianPharma #BulkMedicine #HealthcareDistributor #GlobalHealthcare #MedicalImports #OncologyExport #HealthcareProcurement #CancerMedicineSupplier #ErnestPharmaceutical Online Imatinib Mesylate Tablets Imatinib Mesylate Tablets Supplier India Wholesale Imatinib Tablets Buy Imatinib 100 mg Tablets Imatinib 400 mg Tablet Exporter Tyrosine Kinase Inhibitor Supplier Oncology Tablet Export Company Bulk Cancer Medicine Supplier Pharmaceutical Exporter India 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1

Product Description Granisetron HCl Tablets 1 mg are prescription antiemetic medicines commonly prescribed to reduce nausea and vomiting caused by cancer chemotherapy and radiotherapy. The medicine belongs to the selective 5-HT3 receptor antagonist class, helping patients better tolerate cancer treatment by blocking serotonin signals involved in the vomiting reflex. other medicine ; Ondansetron Tablets 8 mg Aprepitant Capsules 125 mg Dexamethasone Tablets 4 mg Olanzapine Tablets 5 mg Metoclopramide Tablets 10 mg Gefitinib Tablets 250 mg Capecitabine Tablets 500 mg Erlotinib Tablets 150 mg What Other Information Should I Know? -Keep all scheduled follow-up appointments during therapy. -Never use expired tablets or medicines with damaged packaging. -Carry an updated list of all medicines you are taking, especially during hospital visits. -Dispose of unused tablets responsibly according to local pharmaceutical disposal guidelines. -This medicine is intended for individual prescription use and should never be shared with others. Serious Side Effects – Seek Medical Attention Immediately *Difficulty breathing or wheezing *Swelling of the lips, tongue, throat, or face *Severe skin rash, blistering, or peeling *Fast, slow, or irregular heartbeat *Sudden fainting or dizziness *Persistent abdominal swelling or severe constipation *Seizures or loss of consciousness *Symptoms of a severe allergic reaction Safety Advice: ✔ Use only with a valid prescription. ✔ Patients with liver or heart conditions should use this medicine under medical supervision. ✔ Pregnancy and breastfeeding should be discussed with a healthcare provider before treatment. ✔ Avoid driving or operating machinery if you experience dizziness after taking the medicine. Storage Instructions: -Protect from excessive heat, moisture, and direct sunlight. -Store in a dry location away from children and pets. -Do not use the medicine after its expiry date. -Return unused or expired medicines through approved disposal programs whenever possible. Export Documentation Available: regulatory documentation, including: -Certificate of Analysis (COA) -Certificate of Origin (COO) -Commercial Invoice -Packing List -Batch Details -Shipping Documents -Additional export documents as required by the destination country Frequently Asked Questions (FAQs) 1. What are Granisetron HCl Tablets 1 mg used for? They are prescription medicines used to help prevent nausea and vomiting associated with chemotherapy and radiotherapy. 2. Are these tablets available for wholesale export? Yes. Bulk quantities are available for licensed hospitals, pharmaceutical distributors, wholesalers, and authorized importers. 3. Can international buyers request regulatory documents? Yes. Eligible export orders can be supplied with commercial and quality documentation required for international distribution. 4. How should Granisetron Tablets be stored? Keep the tablets in their original packaging, stored in a cool, dry place away from heat, moisture, and direct sunlight. 5. Why do global buyers source Granisetron Tablets from India? Indian pharmaceutical suppliers are recognized for dependable manufacturing standards, competitive export pricing, reliable supply capacity, and extensive experience in serving international healthcare markets. #GranisetronTablets #Granisetron1mg #AntiemeticMedicine #CancerSupport #OncologyCare #HospitalPharmacy #MedicineSupplier #IndianPharma #BulkMedicine #PharmaceuticalExporter #HealthcareDistribution #GlobalPharma #CancerCareSupport #MedicalImports #WholesaleMedicines #HealthcareLogistics #HospitalProcurement #InternationalTrade #PharmaWholesale #ErnestPharmaceutica 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 Granisetron HCl Tablets 1 mg, Buy Granisetron Tablets Online, Antiemetic Medicine Supplier, Oncology Support Medicine, Chemotherapy Nausea Tablets, Pharmaceutical Export India, Wholesale Cancer Support Medicine, Hospital Medicine Distributor, Global Pharma Supplier, Bulk Granisetron Tablets

Geflieva 250mg Tablet: Precision EGFR Inhibition for Advanced Non-Small Cell Lung Cancer Are you searching for a reliable Geflieva 250mg Tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted tyrosine kinase inhibitors. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Geflieva 250mg? Geflieva 250mg is an oral targeted therapy containing the active pharmaceutical ingredient Gefitinib. Manufactured by Allieva Pharma Pvt Ltd, this 250mg tablet is a potent EGFR (Epidermal Growth Factor Receptor) tyrosine kinase inhibitor. It is specifically designed to treat patients with non-small cell lung cancer (NSCLC) that harbors specific activating mutations, offering a targeted alternative to traditional systemic chemotherapy. 1. Therapeutic Indications Metastatic Non-Small Cell Lung Cancer (NSCLC): Indicated as first-line treatment for patients whose tumors have specific EGFR mutations (such as exon 19 deletions or exon 21 L858R substitution mutations). Maintenance Therapy: Used in specific clinical settings to prevent disease progression in patients who have responded to initial platinum-based chemotherapy. Second-line Treatment: Utilized for patients whose cancer has progressed despite receiving prior chemotherapy protocols. 2. Mechanism of Action: Targeted Molecular Blockade EGFR Inhibition: It binds to the adenosine triphosphate (ATP) binding site of the enzyme tyrosine kinase associated with the Epidermal Growth Factor Receptor (EGFR). Signal Disruption: By blocking this site, Geflieva interrupts the signaling pathways (like Ras/Raf/MAPK) that are responsible for cancer cell survival, proliferation, and angiogenesis. Selective Cytotoxicity: Because it targets a specific receptor often overexpressed in lung cancer cells, it effectively inhibits tumor growth while sparing many types of healthy cells. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is one 250mg tablet taken once daily. Administration: Can be taken with or without food. Tablets should be swallowed whole; however, for patients with swallowing difficulties, the tablet can be dispersed in non-carbonated drinking water. Duration: Treatment is generally continued as long as the patient derives clinical benefit without experiencing unacceptable toxicity. Clinical Side Effects & Safety Monitoring Dermatological Safety: Skin rash (acneform) and dry skin are very common; monitoring for severe bullous or exfoliative conditions is required. Gastrointestinal Health: Potential for diarrhea, nausea, and vomiting. Persistent diarrhea may require clinical intervention or dose adjustment. Hepatotoxicity: Periodic Liver Function Tests (LFTs) are recommended as Gefitinib can cause elevations in liver enzymes. Pulmonary Monitoring: Rare but serious risk of Interstitial Lung Disease (ILD). Patients must report new or worsening shortness of breath or cough immediately. Ocular Health: Patients should be monitored for signs of keratitis or corneal erosion. Why Source Geflieva 250mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Geflieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383